Hamish D. Toop

728 total citations
14 papers, 381 citations indexed

About

Hamish D. Toop is a scholar working on Molecular Biology, Organic Chemistry and Immunology and Allergy. According to data from OpenAlex, Hamish D. Toop has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Immunology and Allergy. Recurrent topics in Hamish D. Toop's work include Sphingolipid Metabolism and Signaling (4 papers), Axial and Atropisomeric Chirality Synthesis (3 papers) and Metal-Organic Frameworks: Synthesis and Applications (2 papers). Hamish D. Toop is often cited by papers focused on Sphingolipid Metabolism and Signaling (4 papers), Axial and Atropisomeric Chirality Synthesis (3 papers) and Metal-Organic Frameworks: Synthesis and Applications (2 papers). Hamish D. Toop collaborates with scholars based in Australia, United Kingdom and China. Hamish D. Toop's co-authors include Jonathan C. Morris, Joërg Mattes, Paul S. Foster, Anthony S. Don, Adam Collison, Luke Hatchwell, Nicole M. Verrills, Matthew D. Dun, Qiao Qiao and Hong Zhou and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Hamish D. Toop

13 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hamish D. Toop Australia 9 232 73 62 52 44 14 381
Sandrine Pacquelet France 12 133 0.6× 96 1.3× 55 0.9× 73 1.4× 39 0.9× 18 423
Eman A. Akam United States 11 92 0.4× 45 0.6× 23 0.4× 38 0.7× 43 1.0× 22 342
George Fromm United States 13 415 1.8× 190 2.6× 61 1.0× 62 1.2× 48 1.1× 21 671
Alon Silberman Israel 8 338 1.5× 45 0.6× 24 0.4× 207 4.0× 43 1.0× 11 510
Wanhua Lin China 8 152 0.7× 22 0.3× 28 0.5× 93 1.8× 26 0.6× 11 337
Fangfang Li China 12 183 0.8× 82 1.1× 22 0.4× 114 2.2× 69 1.6× 29 410
Debasish Paul India 14 314 1.4× 35 0.5× 25 0.4× 67 1.3× 34 0.8× 28 462
Majid Motovali-Bashi Iran 11 230 1.0× 40 0.5× 23 0.4× 131 2.5× 25 0.6× 64 401
Sharon Burns United Kingdom 11 157 0.7× 29 0.4× 95 1.5× 40 0.8× 30 0.7× 13 341
N Yu Lukianova Ukraine 11 184 0.8× 53 0.7× 16 0.3× 92 1.8× 61 1.4× 66 447

Countries citing papers authored by Hamish D. Toop

Since Specialization
Citations

This map shows the geographic impact of Hamish D. Toop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamish D. Toop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamish D. Toop more than expected).

Fields of papers citing papers by Hamish D. Toop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamish D. Toop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamish D. Toop. The network helps show where Hamish D. Toop may publish in the future.

Co-authorship network of co-authors of Hamish D. Toop

This figure shows the co-authorship network connecting the top 25 collaborators of Hamish D. Toop. A scholar is included among the top collaborators of Hamish D. Toop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamish D. Toop. Hamish D. Toop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Anderson, Lyndsey L., Kristopher M. Kahlig, Melissa Barker‐Haliski, et al.. (2025). PACFOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures. Epilepsia. 66(12). 4983–4995.
2.
Yang, Wenjie, Weibin Liang, Luke A. O’Dell, et al.. (2021). Insights into the Interaction between Immobilized Biocatalysts and Metal–Organic Frameworks: A Case Study of PCN-333. SHILAP Revista de lepidopterología. 1(12). 2172–2181. 30 indexed citations
3.
Toop, Hamish D., et al.. (2021). Use of modulators and light to control crystallisation of a hydrogen bonded framework. Chemical Communications. 58(2). 306–309. 8 indexed citations
4.
Collison, Adam, Junyao Li, Xuejiao Lv, et al.. (2019). TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis. BMC Pulmonary Medicine. 19(1). 31–31. 24 indexed citations
5.
Toop, Hamish D., et al.. (2017). Concise Total Synthesis of Dioncophylline E through an ortho‐Arylation Strategy. Angewandte Chemie International Edition. 56(29). 8536–8538. 7 indexed citations
6.
Toop, Hamish D., et al.. (2017). Concise Total Synthesis of Dioncophylline E through an ortho‐Arylation Strategy. Angewandte Chemie. 129(29). 8656–8658. 3 indexed citations
7.
Batson, Jennifer, Hamish D. Toop, Clara Redondo, et al.. (2017). Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease. ACS Chemical Biology. 12(3). 825–832. 74 indexed citations
8.
Smith, Amanda M., Matthew D. Dun, Erwin M. Lee, et al.. (2016). Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors. Oncotarget. 7(30). 47465–47478. 35 indexed citations
9.
Toop, Hamish D., et al.. (2016). Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia. Organic & Biomolecular Chemistry. 14(20). 4605–4616. 17 indexed citations
10.
Li, Jing Jing, Hock L. Tay, Steven Maltby, et al.. (2015). MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. Journal of Allergy and Clinical Immunology. 136(2). 462–473. 78 indexed citations
11.
Toop, Hamish D., Anthony S. Don, & Jonathan C. Morris. (2015). Synthesis and biological evaluation of analogs of AAL(S) for use as ceramide synthase 1 inhibitors. Organic & Biomolecular Chemistry. 13(48). 11593–11596. 6 indexed citations
12.
Collison, Adam, Junyao Li, Jie Zhang, et al.. (2014). Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Regulates Hallmark Features of Airways Remodeling in Allergic Airways Disease. American Journal of Respiratory Cell and Molecular Biology. 51(1). 86–93. 32 indexed citations
13.
Hatchwell, Luke, Jason Girkin, Matthew D. Dun, et al.. (2014). Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A. Journal of Allergy and Clinical Immunology. 133(6). 1720–1727. 33 indexed citations
14.
Qiao, Qiao, et al.. (2012). A fluorescent assay for ceramide synthase activity. Journal of Lipid Research. 53(8). 1701–1707. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026